In the evolving field of longevity research, few subjects have garne Klotho antiaging protein: molecular mechanisms and - PMC red as much attention as Klotho. Often referred to by enthusiasts as Mar 11, 2026 — It is a protein produced by the kidneys and brain. This compound is called the “anti-aging protein.” Scientists first discovered it in 1997. the "anti-aging hormone," this fascinating molecule occupies a unique space in biological studies. A common question I encounter among researchers and protein science hobbyists is: Is Klotho a peptide?
To answer this accurately, we must distinguish between the full-length protein and the specific fragments derived from it.
Defining the Entity: What is Klotho?
At its core, Klotho is a single-pass 130-kD transmembrane protein th by GJ Prud’homme · 2022 · Cited by 276 — The α-Klotho protein (henceforth denoted Klotho) has antiaging properties, as first observed in mice homozygous for a hypomorphic Klotho gene (kl/kl). at acts as a systemic anti-aging hormone within the glycosidase-1 superfamily. First discovered in 1997, it was identified as an anti-aging gene that, when expressed at higher levels in mouse models, appeared to significantly extend lifespan and improve physical and cognitive function.
The full-length protein is primarily produced in the kidneys and brain, though it is also expressed in the pancreas. It functions as an obligate co-receptor for fibroblast growth factor 23 (FGF23) and plays a vital role in regulating mineral balance, specifically calcium and phosphate levels. Because it is a large, complex structure, it is categorized as a protein rather than a simple chain of amino Aug 6, 2023 — Klotho was first discovered as the antiaging gene in 1997 when researchers found that enhancing its expression could increase the lifespan of mice by more than acids.
Is Klotho a Peptide? The Distinction Explained
While the full-length structure is a protein, the answer to "is Klotho a peptide" depends on the context of the molecule being discussed. In laboratory settings, scientists often isolate specific sequences from the larger protein to study their individual functions. These fragments are indeed peptides.
A peptide is a short chain of amino acids, and in recent years, researchers have synthesized specific segments of the Klotho protein to explore their unique signaling properties. For instance:
* Klotho-derived peptide 1 (KP1): T Human Klotho Synthetic Peptide (PEP-1192) his is a peptide originating from the human Klotho protein. It has become a significant subject of study because it functions as a TGF-β signaling inhibitor. By binding to TGF-β receptor 2, KP1 has shown promise in experimental models for its potential to protect against tissue fibrosis.
* Klotho-derived peptide 6: This variant acts as a β-catenin signaling inhibitor. It works by sequestering Wnt ligands, preventin Klotho-derived peptide 1 Supplier g the downstream expression of fibronectin, which is a key marker in cellular aging and degradation processes.
Why These Fragments Matter
As a natural protein made by your body, Klotho is a powerful anti-aging signaling protein that regulates inflammation, oxidative stress, and stem cell activity. However, because the full protein is large and difficult to synthesize or deliver, these smaller, lab-engineered peptides offer a more streamlined way to study how the body’s natural anti-aging mechanisms work.
When we look at the literature, it is clear that Klotho is an anti-aging protein with diverse isoforms. Whether it is the full-length transmembrane protein or a specific, isolated fragment, the molecule remains a focal point for understanding how we might one day harness biological pathways to support healthy aging.
Summary of Findings
To summarize the current state of knowledge regarding these compounds:
1. Klotho is a complex, 130-kD transmembrane protein.
2. Peptides derived fr by Q Yuan · 2022 · Cited by 171 — Klotho is an anti-aging protein that is highly expressed in kidney tubular epithelia. It is a single-pass transmembrane protein and functions as om this protein, such as KP1, are synthetic fragments used to target specific signaling pathways like TGF-β.
3. The distinction is critical: while the body produces the full protein to regulate systemic health, the "Klotho peptides" circulating in research circles are specific, targeted tools developed for precise biological investigation.
As someone who tracks the development of these molecules, it is exciting to see how researchers continue to refine our understanding of this longevity-linked protein. Whether you are investigating the systemic effects of the full protein or the specific signaling inhibition of a derived fragment, the science remains one of the most promising frontiers in modern biology.